A Novel Acinetobacter baumannii Bacteriophage Endolysin LysAB54 With High Antibacterial Activity Against Multiple Gram-Negative Microbes

The rapid spread and emergence of multidrug-resistant Acinetobacter baumannii and other pathogenic Gram-negative bacteria spurred scientists and clinicians to look for alternative therapeutic agents to conventional antibiotics. In the present study, an A. baumannii bacteriophage p54 was isolated and...

Full description

Bibliographic Details
Main Authors: Fazal Mehmood Khan, Vijay Singh Gondil, Changchang Li, Mengwei Jiang, Junhua Li, Junping Yu, Hongping Wei, Hang Yang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2021.637313/full
_version_ 1818413100671434752
author Fazal Mehmood Khan
Fazal Mehmood Khan
Vijay Singh Gondil
Changchang Li
Changchang Li
Mengwei Jiang
Junhua Li
Junping Yu
Junping Yu
Hongping Wei
Hongping Wei
Hang Yang
Hang Yang
author_facet Fazal Mehmood Khan
Fazal Mehmood Khan
Vijay Singh Gondil
Changchang Li
Changchang Li
Mengwei Jiang
Junhua Li
Junping Yu
Junping Yu
Hongping Wei
Hongping Wei
Hang Yang
Hang Yang
author_sort Fazal Mehmood Khan
collection DOAJ
description The rapid spread and emergence of multidrug-resistant Acinetobacter baumannii and other pathogenic Gram-negative bacteria spurred scientists and clinicians to look for alternative therapeutic agents to conventional antibiotics. In the present study, an A. baumannii bacteriophage p54 was isolated and characterized. Morphological and genome analysis revealed that bacteriophage p54 belongs to Myoviridae family with a genome size of 165,813 bps. A novel endolysin, namely LysAB54, showing low similarity with other well-known related endolysins, was cloned, expressed, and characterized from the bacteriophage p54. LysAB54 showed significant bactericidal activity against multidrug-resistant A. baumannii and other Gram-negative bacteria, including Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli, in the absence of outer membrane permeabilizers. Based on all those observations, LysAB54 could represent a potential agent for the treatment of multidrug-resistant Gram-negative superbugs.
first_indexed 2024-12-14T10:57:50Z
format Article
id doaj.art-5120de0fe7664d4ea1a82ba517b3fee7
institution Directory Open Access Journal
issn 2235-2988
language English
last_indexed 2024-12-14T10:57:50Z
publishDate 2021-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular and Infection Microbiology
spelling doaj.art-5120de0fe7664d4ea1a82ba517b3fee72022-12-21T23:04:52ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882021-03-011110.3389/fcimb.2021.637313637313A Novel Acinetobacter baumannii Bacteriophage Endolysin LysAB54 With High Antibacterial Activity Against Multiple Gram-Negative MicrobesFazal Mehmood Khan0Fazal Mehmood Khan1Vijay Singh Gondil2Changchang Li3Changchang Li4Mengwei Jiang5Junhua Li6Junping Yu7Junping Yu8Hongping Wei9Hongping Wei10Hang Yang11Hang Yang12CAS Key Laboratory of Special Pathogens and Biosafety, Center for Biosafety Mega-Science, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, ChinaInternational College, University of Chinese Academy of Sciences, Beijing, ChinaCAS Key Laboratory of Special Pathogens and Biosafety, Center for Biosafety Mega-Science, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, ChinaCAS Key Laboratory of Special Pathogens and Biosafety, Center for Biosafety Mega-Science, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, ChinaInternational College, University of Chinese Academy of Sciences, Beijing, ChinaCAS Key Laboratory of Special Pathogens and Biosafety, Center for Biosafety Mega-Science, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, ChinaCAS Key Laboratory of Special Pathogens and Biosafety, Center for Biosafety Mega-Science, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, ChinaCAS Key Laboratory of Special Pathogens and Biosafety, Center for Biosafety Mega-Science, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, ChinaInternational College, University of Chinese Academy of Sciences, Beijing, ChinaCAS Key Laboratory of Special Pathogens and Biosafety, Center for Biosafety Mega-Science, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, ChinaInternational College, University of Chinese Academy of Sciences, Beijing, ChinaCAS Key Laboratory of Special Pathogens and Biosafety, Center for Biosafety Mega-Science, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, ChinaInternational College, University of Chinese Academy of Sciences, Beijing, ChinaThe rapid spread and emergence of multidrug-resistant Acinetobacter baumannii and other pathogenic Gram-negative bacteria spurred scientists and clinicians to look for alternative therapeutic agents to conventional antibiotics. In the present study, an A. baumannii bacteriophage p54 was isolated and characterized. Morphological and genome analysis revealed that bacteriophage p54 belongs to Myoviridae family with a genome size of 165,813 bps. A novel endolysin, namely LysAB54, showing low similarity with other well-known related endolysins, was cloned, expressed, and characterized from the bacteriophage p54. LysAB54 showed significant bactericidal activity against multidrug-resistant A. baumannii and other Gram-negative bacteria, including Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli, in the absence of outer membrane permeabilizers. Based on all those observations, LysAB54 could represent a potential agent for the treatment of multidrug-resistant Gram-negative superbugs.https://www.frontiersin.org/articles/10.3389/fcimb.2021.637313/fullbacteriophageendolysinAcinetobacter baumanniiGram-negative “superbugs”antimicrobial resistance
spellingShingle Fazal Mehmood Khan
Fazal Mehmood Khan
Vijay Singh Gondil
Changchang Li
Changchang Li
Mengwei Jiang
Junhua Li
Junping Yu
Junping Yu
Hongping Wei
Hongping Wei
Hang Yang
Hang Yang
A Novel Acinetobacter baumannii Bacteriophage Endolysin LysAB54 With High Antibacterial Activity Against Multiple Gram-Negative Microbes
Frontiers in Cellular and Infection Microbiology
bacteriophage
endolysin
Acinetobacter baumannii
Gram-negative “superbugs”
antimicrobial resistance
title A Novel Acinetobacter baumannii Bacteriophage Endolysin LysAB54 With High Antibacterial Activity Against Multiple Gram-Negative Microbes
title_full A Novel Acinetobacter baumannii Bacteriophage Endolysin LysAB54 With High Antibacterial Activity Against Multiple Gram-Negative Microbes
title_fullStr A Novel Acinetobacter baumannii Bacteriophage Endolysin LysAB54 With High Antibacterial Activity Against Multiple Gram-Negative Microbes
title_full_unstemmed A Novel Acinetobacter baumannii Bacteriophage Endolysin LysAB54 With High Antibacterial Activity Against Multiple Gram-Negative Microbes
title_short A Novel Acinetobacter baumannii Bacteriophage Endolysin LysAB54 With High Antibacterial Activity Against Multiple Gram-Negative Microbes
title_sort novel acinetobacter baumannii bacteriophage endolysin lysab54 with high antibacterial activity against multiple gram negative microbes
topic bacteriophage
endolysin
Acinetobacter baumannii
Gram-negative “superbugs”
antimicrobial resistance
url https://www.frontiersin.org/articles/10.3389/fcimb.2021.637313/full
work_keys_str_mv AT fazalmehmoodkhan anovelacinetobacterbaumanniibacteriophageendolysinlysab54withhighantibacterialactivityagainstmultiplegramnegativemicrobes
AT fazalmehmoodkhan anovelacinetobacterbaumanniibacteriophageendolysinlysab54withhighantibacterialactivityagainstmultiplegramnegativemicrobes
AT vijaysinghgondil anovelacinetobacterbaumanniibacteriophageendolysinlysab54withhighantibacterialactivityagainstmultiplegramnegativemicrobes
AT changchangli anovelacinetobacterbaumanniibacteriophageendolysinlysab54withhighantibacterialactivityagainstmultiplegramnegativemicrobes
AT changchangli anovelacinetobacterbaumanniibacteriophageendolysinlysab54withhighantibacterialactivityagainstmultiplegramnegativemicrobes
AT mengweijiang anovelacinetobacterbaumanniibacteriophageendolysinlysab54withhighantibacterialactivityagainstmultiplegramnegativemicrobes
AT junhuali anovelacinetobacterbaumanniibacteriophageendolysinlysab54withhighantibacterialactivityagainstmultiplegramnegativemicrobes
AT junpingyu anovelacinetobacterbaumanniibacteriophageendolysinlysab54withhighantibacterialactivityagainstmultiplegramnegativemicrobes
AT junpingyu anovelacinetobacterbaumanniibacteriophageendolysinlysab54withhighantibacterialactivityagainstmultiplegramnegativemicrobes
AT hongpingwei anovelacinetobacterbaumanniibacteriophageendolysinlysab54withhighantibacterialactivityagainstmultiplegramnegativemicrobes
AT hongpingwei anovelacinetobacterbaumanniibacteriophageendolysinlysab54withhighantibacterialactivityagainstmultiplegramnegativemicrobes
AT hangyang anovelacinetobacterbaumanniibacteriophageendolysinlysab54withhighantibacterialactivityagainstmultiplegramnegativemicrobes
AT hangyang anovelacinetobacterbaumanniibacteriophageendolysinlysab54withhighantibacterialactivityagainstmultiplegramnegativemicrobes
AT fazalmehmoodkhan novelacinetobacterbaumanniibacteriophageendolysinlysab54withhighantibacterialactivityagainstmultiplegramnegativemicrobes
AT fazalmehmoodkhan novelacinetobacterbaumanniibacteriophageendolysinlysab54withhighantibacterialactivityagainstmultiplegramnegativemicrobes
AT vijaysinghgondil novelacinetobacterbaumanniibacteriophageendolysinlysab54withhighantibacterialactivityagainstmultiplegramnegativemicrobes
AT changchangli novelacinetobacterbaumanniibacteriophageendolysinlysab54withhighantibacterialactivityagainstmultiplegramnegativemicrobes
AT changchangli novelacinetobacterbaumanniibacteriophageendolysinlysab54withhighantibacterialactivityagainstmultiplegramnegativemicrobes
AT mengweijiang novelacinetobacterbaumanniibacteriophageendolysinlysab54withhighantibacterialactivityagainstmultiplegramnegativemicrobes
AT junhuali novelacinetobacterbaumanniibacteriophageendolysinlysab54withhighantibacterialactivityagainstmultiplegramnegativemicrobes
AT junpingyu novelacinetobacterbaumanniibacteriophageendolysinlysab54withhighantibacterialactivityagainstmultiplegramnegativemicrobes
AT junpingyu novelacinetobacterbaumanniibacteriophageendolysinlysab54withhighantibacterialactivityagainstmultiplegramnegativemicrobes
AT hongpingwei novelacinetobacterbaumanniibacteriophageendolysinlysab54withhighantibacterialactivityagainstmultiplegramnegativemicrobes
AT hongpingwei novelacinetobacterbaumanniibacteriophageendolysinlysab54withhighantibacterialactivityagainstmultiplegramnegativemicrobes
AT hangyang novelacinetobacterbaumanniibacteriophageendolysinlysab54withhighantibacterialactivityagainstmultiplegramnegativemicrobes
AT hangyang novelacinetobacterbaumanniibacteriophageendolysinlysab54withhighantibacterialactivityagainstmultiplegramnegativemicrobes